In vitro activity of daptomycin against Staphylococcus aureus and vancomycin-resistant Enterococcus faecium isolates associated with skin and soft tissue infections: first results from India

Diagnostic Microbiology and Infectious Disease

Volumn 65, Issue 2, 2009, Pages 196-198

  Dhawan, Benu ^a   Gadepalli, Ravisekhar ^a   Kapil, Arti ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Antimicrobial susceptibility; Broth microdilution; Daptomycin; Staphylococcus aureus; Vancomycin resistant Enterococcus faecium

Indexed keywords

CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; ERYTHROMYCIN; GENTAMICIN; LINEZOLID; PENICILLIN G; STREPTOMYCIN; TEICOPLANIN; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENTEROCOCCUS FAECIUM; HOSPITAL PATIENT; HUMAN; IN VITRO STUDY; INDIA; MEDICAL DECISION MAKING; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; DAPTOMYCIN; ENTEROCOCCUS FAECIUM; HOSPITALIZATION; HUMANS; INDIA; MICROBIAL SENSITIVITY TESTS; SKIN DISEASES, BACTERIAL; SOFT TISSUE INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANCE;

EID: 69949083490     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2009.05.015     Document Type: Article

References (16)

1. Baird D. Staphylococcus: cluster-forming Gram-positive cocci. In: Collee A.G., Fraser B.P., Marmion J.G., and Simmons A. (Eds). Mackie & McCartney practical medical microbiology. fourteenth ed. (1996), Churchill Livingstone, New York 245-261
2. Bowler P.G., Duerden B.I., and Armstrong D.G. Wound microbiology and associated approaches to wound management. Clin. Microbiol. Rev 14 (2001) 244-269
3. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial disk susceptibility tests; approved standard-eleventh edition, M2-A7 (2005), CLSI, Wayne, PA
4. Clinical and Laboratory Standards Institute (CLSI). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-seventeenth edition, M7-A7 (2006), CLSI, Wayne, PA
5. Doern G.V., Jones R.N., Pfaller M.A., Kugler K.C., and Beach M.L. Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). SENTRY Study Group (North America). Diagn. Microbiol. Infect. Dis. 34 (1999) 65-72
6. Facklam R.R., and Collins M.D. Identification of Enterococcus species isolated from human infections by a conventional test scheme. J. Clin. Microbiol. 27 (1989) 731-734
7. Fuchs P.C., Barry A.L., and Brown D. Daptomycin susceptibility tests: interpretative criteria, quality control, and effect of calcium on in vitro tests. Diagn. Microbiol. Infect. Dis. 38 (2000) 51-58
8. Giamarellou H. Treatment options for multidrug-resistant bacteria. Expert. Rev. Anti. Infect. Ther. 4 (2006) 601-618
9. Gonzales R.D., Schreckenberger P.C., Graham M.B., Kelkar S., DenBesten K., and Quinn J.P. Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid. Lancet 357 (2001) 1179
10. Jones R.N. Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains. Clin. Infect. Dis. 1 42 Suppl (2006) S13-S24
11. Livermore D.M. Quinupristin/dalfopristin and linezolid: where, when, which and whether to use?. J. Antimicrob. Chemother. 46 (2000) 347-350
12. Lundstrom T.S., and Sobel J.D. Antibiotics for Gram-positive bacterial infections: vancomycin, quinupristin-dalfopristin, linezolid and daptomycin. Infect. Dis. Clin. North. Am. 18 (2004) 651-668
13. Menichetti F. Current and emerging serious Gram-positive infections. Clin. Microbiol. Infect. . 11 Suppl 3 (2005) 22-28
14. Ramos-Trujillo E., Pérez-Roth E., Méndez-Alvarez S., and Claverie-Martín F. Multiplex PCR for simultaneous detection of enterococcal genes vanA and vanB and staphylococcal genes mecA, ileS-2 and femB. Int. Microbiol. 6 (2003) 113-115
15. Sader H.S., Watters A.A., Fritsche T.R., and Jones R.N. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005). BMC. Infect. Dis. 7 (2007) 29
16. Steenbergen J.N., Alder J., Thorne G.M., and Tally F.P. Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections. J. Antimicrob. Chemother. 55 (2005) 283-288